Global Health Experts Unite to Highlight Steatotic Liver Disease

May 22, 2025 - 10:22

Geneva, Switzerland, May 22, 2025 – Leading health organizations, policymakers, and public health advocates gathered at a pivotal side event during the 78th World Health Assembly to advocate for the recognition of steatotic liver disease as a core non-communicable disease. The event aimed to raise awareness about the growing prevalence of this condition, which is often linked to obesity and metabolic syndrome.

Participants emphasized the urgent need for global health initiatives to address the rising rates of steatotic liver disease, which can lead to severe complications, including liver cirrhosis and cancer. Experts presented data illustrating the increasing burden of this disease on healthcare systems worldwide and called for enhanced research funding and public health strategies.

The discussions also focused on the importance of integrating steatotic liver disease into broader non-communicable disease frameworks, advocating for comprehensive prevention and treatment strategies. By elevating the profile of this condition, health leaders hope to mobilize resources and foster collaboration aimed at reducing its impact on global health.